North American Pediatric Allergy and Asthma Congress 2024
Early Bird Pricing: $395 for ACAAI/CSACI members, $595 non-members, $125 students/residents/FITs, $695 non-exhibiting industry attendees
After February 2, 2024, $595 for ACAAI/CSACI members, $795 non-members, $225 students/residents/FITs, $795 non-exhibiting industry attendees
**CSACI members only - use coupon code CSACI24 during checkout for discounted price**
Don’t miss this exciting opportunity to be part of the 2nd North American Pediatric Allergy and Asthma Congress (NAPAAC) that will take place April 12-14, 2024, at the JW Marriott Las Vegas Resort & Spa. This 3-day CME program – developed jointly by the American College of Allergy, Asthma and Immunology (ACAAI) and the Canadian Society of Allergy and Clinical Immunology (CSACI) – will focus entirely on pediatric allergies and related conditions.
NAPAAC aims to deliver state of the art evidence-based practical approaches to assist diagnosis and management of common pediatric conditions. Sessions are designed to be engaging, interactive, and entertaining. Attendees will not only learn pearls to apply immediately into clinical practice, but will hear experts in the specialty of allergy/immunology offer insight and perspective regarding new paradigms of care.
Plan now to join us for NAPAAC 2024: Advances in Pediatric Allergy: Moving Towards Proactive Management
Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 15.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CBRN
The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP17239, for 15.75 contact hours.
Target Audience
Allergists, pediatricians and other allergy healthcare providers.
Learning Objectives
At the conclusion of this activity learners should be able to…
1. Translate new evidence regarding treatment of allergic conditions into clinical practice
2. Incorporate shared decision making with patients surrounding various management options
3. Utilize an individualized approach for patients with food allergy, allergic rhinitis and asthma
4. Increase awareness surrounding paradigm shifts in prevention, diagnosis and management
NAPAAC 2024 PROGRAM | ||
FRIDAY APRIL 12 | ||
11:00 am - 1:00 pm | Registration | |
1:00 pm - 1:15 pm | Welcome/Introductions | David Stukus, MD, Douglas Mack, MD, MSc |
1:15 pm - 2:00 pm | Keynote Presentation Overcoming Inertia: Implementing Current Evidence Based Medicine into Clinical Practice | Timothy Caulfield, BSc, LL.B, LL.M |
2:00 pm - 2:30 pm | Let the Babies Eat: Instilling Confidence Surrounding Early Introduction of Allergenic Foods | Mimi Tang, MBBS, PhD |
2:30 pm - 3:00 pm | Prognosis from an Early Age: How to use Phenotyping to Guide Management of Asthma, Atopic Dermatitis, and Food Allergy | David Stukus, MD |
3:00 pm - 3:15 pm | Q & A | Douglas Mack, MD, MSc, David Stukus, MD |
3:15 pm - 3:30 pm | Break | |
3:30 pm - 4:00 pm | Pro/Con: Penicillin Allergy Delabeling Should be Done in Primary Care Offices | Maureen Petersen, MD, Moshe Ben-Shoshan, MD, MSc |
4:00 pm - 4:30 pm | Lessons Learned From the COVID-19 Pandemic: Why We Can’t Go Back to the Way Things Were | Victoria Cook, MSc, MD |
4:30 pm - 5:30 pm | Happy Hour/Fireside Chat with Dave and Friends | David Stukus, MD, Timothy Caulfield, BSc, LL.B, LL.M, Mimi Tang, MBBS, PhD |
5:45 pm - 7:15 pm | NonCME Industry Forum Dinner | |
SATURDAY APRIL 13 | ||
7:00 am - 7:45 am | Breakfast Symposium New Paradigms in the Management of Anaphylaxis | Jay Lieberman, MD |
7:45 am - 8:30 am | Keynote Presentation If You're Not Using Shared Decision Making for Atopic Conditions, then You're Doing it All Wrong | Matthew Greenhawt, MD, MBA, MSc |
8:30 am- 9:00 am | Managing Asthma in Children: When to Step Up and When to Step Down | William Anderson, MD |
9:00 am - 9:15 am | Q & A | Douglas Mack, MD, MSc, David Stukus, MD |
9:15 am - 9:45 am | Break/Visit Exhibit Hall | |
9:45 am - 10:15 am | Why Everything You Thought You Knew About Atopic Dermatitis is Outdated | Vikash Oza, MD |
10:15 am - 10:45 am | The Most Practical Talk About Diagnosing Food Allergy That You’ve Ever Heard (AKA: Why panel food testing really hurts) | Mariam Hanna, MD |
10:45 am - 11:15 am | Who, When, Why and How to Start an Evaluation for Primary Immune Deficiency | Ben Prince, MD, MSCI |
11:15 am - 11:45 am | Pro/Con: Baked Food Ingestion Hastens the Resolution of Food Allergy | Anna Nowak-Wegrzyn, MD, PhD Mimi Tang, MBBS, PhD |
11:45 am - 12:00 pm | Fido’s Gotta Go: Top 10 Practical Tips for Managing Allergic Rhinoconjunctivitis in Children | Syed Shahzad Mustafa, MD |
12:00 pm - 12:10 pm | Q & A | David Stukus, MD, Douglas Mack, MD, MSc |
12:10 pm - 1:00 pm | Lunch in Exhibit Hall | |
1:00 pm - 1:45 pm | Selecting the Best Biologic for Your Patient | Shahzad Mustafa, MD |
1:45 pm - 2:45 pm | Breakout Session 1A Challenging Cases: Diagnostic Dilemmas (Immune deficiency, non-IgE food allergy, asthma, adverse drug reactions) | William Anderson, MD, Ben Prince, MD, MSCI, Anna Nowak-Wegrzyn, MD, PhD, Moshe Ben-Shoshan, MD, MSc |
1:45 pm - 2:45 pm | Breakout Session 2A Challenging Cases: Management Dilemmas (Asthma, atopic dermatitis, adverse vaccine/drug reactions) | Vikash Oza, MD, Shahzad Mustafa, MD, Matthew Greenhawt, MD, MBA, MSc, Maureen Peterson, MD |
1:45 pm - 2:45 pm | Breakout Session 3A Challenging Cases: Dr. Google, Nonadherence, and Resistance to Change | Purvi Parikh, MD, Mariam Hanna, MD, David Stukus, MD |
2:45 pm - 3:15 pm | Break in Exhbit Hall / Change Breakouts | |
3:15 pm - 4:15 pm | Breakout Session 1B Challenging Cases: Diagnostic Dilemmas (Immune deficiency, non-IgE food allergy, asthma, adverse drug reactions) | William Anderson, MD, Ben Prince, MD, MSCI, Anna Nowak-Wegrzyn, MD, PhD, Moshe Ben-Shoshan, MD, MSc |
3:15 pm - 4:15 pm | Breakout Session 2B Challenging Cases: Management Dilemmas (Asthma, atopic dermatitis, adverse vaccine/drug reactions) | Vikash Oza, MD, Shahzad Mustafa, MD, Matthew Greenhawt, MD, MBA, MSc, Maureen Peterson, MD |
3:15 pm - 4:15 pm | Breakout Session 3B Challenging Cases: Dr. Google, Nonadherence, and Resistance to Change | Purvi Parikh, MD, Mariam Hanna, MD, David Stukus, MD |
4:20 pm - 5:00 pm | Stump the Expert with Doug and Friends | Douglas Mack, MD, MSc |
5:00 pm - 6:00 pm | NAPAAC Reception Social Hour in the Exhibit Hall | |
6:15 pm - 7:45 pm | NonCME Industry Forum Dinner | |
SUNDAY APRIL 14 | ||
7:00 am - 8:00 am | Breakfast Symposium How to Use Shared Decision Making to Guide Management of Eosinophilic Esophagitis | Natacha Tardio, MD |
8:00 am - 8:30 am | Changing the course of allergic rhinitis – a focus on sublingual immunotherapy | Douglas Mack, MD, MSc |
8:30 am - 9:00 am | Pro/Con: Mast Cell Activation Syndrome is More Common Than We Think | Moshe Ben-Shoshan, MD, MSc, Matthew Greenhawt, MD, MBA, MSc |
9:15 am - 9:30 am | Q&A | David Stukus, MD, Douglas Mack, MD, MSc |
9:30 am - 10:00 am | Break/Visit Exhibit Hall | |
10:00 am - 10:30 am | It’s Time to Rethink Our Use of First Generation Antihistamines | Elissa Abrams, MD, MPH |
10:30 am - 11:00 am | Food Oral Immunotherapy: Risks, Benefits, and Expected Outcomes | Mimi Tang, MBBS, PhD |
11:00 am - 11:30 am | Transitioning Adolescents with Allergic Conditions Towards Independence | William Anderson, MD |
11:30 pm - 12:00 pm | The Best Mandatory Wellness Talk You’ll Ever Get | David Stukus, MD |
12:00 pm - 12:15 pm | Q & A | Douglas Mack, MD, MSc |
12:15 pm - 12:30 pm | Closing Remarks | David Stukus, MD, Douglas Mack, MD, MSc |
Hotel Room Rate & Resort Fee: $219 Single / Double + 13% tax and a reduced Resort Fee of $40 / night
Reserve Online: https://book.passkey.com/e/50547027
Planners, Faculty & Disclosures
All identified relevant financials relationships with ineligible companies have been mitigated.
Elissa Abrams, MD: Planner, Speaker - no relevant financial relationships with ineligible companies to disclose
William Anderson, MD: Speaker - Advisor: Genentech, Regeneron, Sanofi
Moshe Ben-Shosham, MD, MSc: Planner, Speaker - Speaker: Novartis, Stallergenes Greer, Sanofi, Medexsus
Timothy Caulfield, BSc, LL.B, LL.M: Speaker - no relevant financial relationships with ineligible companies to disclose
Victoria Cook, MSc, MD: Planner, Speaker - Speaker: Aralez Pharma, Pfizer
Matt Greenhawt, MD, MBA, MSc: Speaker - Advisor: AstraZeneca, Alk-Abello, DBV Technologies, Genentech, Novartis; Researcher: DBV Technologies, Novartis
Mariam Hanna, MD: Planner, Speaker - Advisor: ALK, Trudell; Speaker: ALK, Covis, Trudell, Medexus, Pfizer, Researcher: ALKDBV, AstraZeneca; Consultant: ALK
Jay Lieberman, MD: Speaker - Researcher: DBV Technologies, Novartis, Regeneron
Douglas Mack, MD: Co-Chair, Planner, Speaker - Researcher: DBV, AstraZeneca, Dermavent, Arcutis, ALK; Speaker: Bausch, Covis, Medexus
Syed Shahzad Mustafa, MD: Speaker - Speaker: Genentech, AstraZeneca, GlaxoSmithKline, Regeneron; Advisor: AstraZeneca
Anna Nowak-Wegrzyn, MD: Planner, Speaker - Advisor: Nestle; Speaker: Nutricia, Thermofisher Scientific; Researcher: Nutricia, DBV; Consultant: Nestle, Labcorp, Hamimmune
Vikash Oza, MD: Speaker - Consultant: Dermavant, Regeneron, Apogee; Advisor: Cerave; Researcher: Pfizer
Purvi Parikh, MD: Planner, Speaker - Advisor: Genentech, Moderna, Takeda; Speaker: AstraZeneca, Takeda
Maureen Petersen, MD: Planner, Speaker - no relevant financial relationships with ineligible companies to disclose
Benjamin T. Prince, MD, MSCI: Planner, Speaker - Advisor, Sanofi
David Stukus, MD, FACAAI: Co-Chair, Planner, Speaker - Researcher: DBV Technologies; Consultant: Kaleo Pharmaceuticals, Novartis, ARS Pharmaceuticals
Mimi Tang, MBBS, PhD: Speaker - Advisor: Novartis
Natacha Tardio, MD: Speaker - Advisor: Sanofi; Speaker: Sanofi, Amgen, AstraZeneca
Staff Disclosures
Jasmin Lidington, CAE: Planner - no relevant financial relationships with ineligible companies to disclose
Mary Carol Badat, MAdEd: Planner - no relevant financial relationships with ineligible companies to disclose
Available Credit
- 15.75 AMA PRA Category 1 Credit™
- 15.75 Attendance
- 15.75 CBRN
EXHIBITORS & INDUSTRY PARTNERS
Don’t miss this exciting opportunity to be part of the 2nd North American Pediatric Allergy and Asthma Congress (NAPAAC) that will take place April 12-14, 2024, at the JW Marriott Las Vegas Resort & Spa. This 3-day CME program – developed jointly by the American College of Allergy, Asthma and Immunology (ACAAI) and the Canadian Society of Allergy and Clinical Immunology (CSACI) – will focus entirely on pediatric allergies and related conditions, with cuttting-edge, interactive presentations.
Plan now to exhibit at NAPAAC 2024: Advances in Pediatric Allergy: Moving Towards Proactive Management. A wide variety of sponsorship opportunties are also available.
Download the EXHIBITOR & SPONSORSHIP PROSPECTUS
Price
**CSACI members - use coupon code CSACI24 during checkout for discounted price**
Questions about making a payment? We use PayPal to process credit card payments, but you do not need a PayPal account to register.
Download our instructional sheet